Recovery, Monitoring, and Your Life After CTEPH Treatment
At a Glance
After CTEPH treatment like PEA or BPA, patients require lifelong monitoring and must take permanent blood thinners to prevent new clots. While many experience significant improvement, some develop residual pulmonary hypertension that requires additional targeted medication or procedures.
Treatment for CTEPH is not a single event but the beginning of a long-term journey toward recovery and health. While procedures like Pulmonary Endarterectomy (PEA) or Balloon Pulmonary Angioplasty (BPA) provide the mechanical fix, your body requires time, monitoring, and potentially further adjustments to fully heal.
The Immediate Hospital Recovery for PEA Surgery
Because PEA is a major open-heart operation, the immediate recovery is intensive. Patients should expect:
- The Intensive Care Unit (ICU): Directly after surgery, you will spend several days in the ICU connected to a ventilator to help you breathe, along with monitors to track your heart closely.
- Chest Tubes: You will wake up with tubes in your chest to drain excess fluid and blood from the surgical site. These are standard and will be removed after a few days.
- Hospital Stay: The total hospital stay is typically 1 to 2 weeks, depending on how quickly you regain your strength and how well your lungs adjust to the renewed blood flow.
- Going Home: The first few weeks at home require significant rest. Your chest bone (sternum) needs time to heal, and you will slowly rebuild your stamina through guided, light activities [1].
Milestones for the First Year
Whether you had PEA surgery or multiple BPA sessions, you will have regular check-ins:
- The 3- to 6-Month Mark: This is a vital milestone. Your team will likely perform a 6-minute walk distance (6MWD) test, an echocardiogram, and often a repeat Right Heart Catheterization (RHC) to see exactly how much your heart pressures have dropped [2][3].
- The 1-Year Mark: By this time, many patients experience “reverse remodeling.” This means the right side of the heart, which was stretched and strained by the disease, begins to shrink back to a more normal size and shape [4].
Managing “Residual” Pulmonary Hypertension
Surgery or BPA cannot always reach 100% of the disease. Approximately 25% of patients who undergo PEA have some residual pulmonary hypertension—meaning their lung pressures remain higher than normal even after the major scars are removed [5][6].
If you have residual PH, your journey isn’t over; your team simply shifts strategy. They may recommend:
- Medical Therapy: Targeted medications (like Riociguat or other pulmonary hypertension drugs) can be added to help relax the remaining vessels and improve blood flow [7][8].
- Supplemental BPA: For some, a few sessions of balloon pulmonary angioplasty can be used to “clean up” smaller blockages that the surgeon couldn’t reach [9][10].
Life After Treatment: Monitoring and Wellness
Even if you feel wonderful, CTEPH requires lifelong vigilance.
- Lifelong Blood Thinners: To prevent new clots from forming, you must remain on anticoagulation for the rest of your life [11]. Never pause these without consulting your specialist.
- Regular Check-ups: Routine echocardiograms and walk tests help your team catch any changes early. “Scan anxiety” is a real and valid experience for many patients, but these tests are your safety net [12][13].
- Quality of Life: The ultimate goal is returning to the activities you love. Most patients see significant, sustained improvements in their physical ability for five years and beyond [1][14].
The Emotional Road Ahead
Living with a chronic condition like CTEPH can take a psychological toll. Anxiety and depression are common, as the stress of the original misdiagnosis and the demands of lifelong monitoring are significant [12]. Do not hesitate to seek support through specialized counselors or patient advocacy groups like the Pulmonary Hypertension Association (PHA). Connecting with others who have walked this path can be one of the most powerful tools in your recovery.
Common questions in this guide
What can I expect immediately after PEA surgery for CTEPH?
Will I still have pulmonary hypertension after CTEPH treatment?
What tests will I need during my first year of CTEPH recovery?
Do I need to take blood thinners forever after CTEPH treatment?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What does my hemodynamic report from the 3-6 month mark say about residual pulmonary hypertension?
- 2.If I have residual PH, should we discuss adding medication or scheduling supplemental BPA sessions?
- 3.How often will I need echocardiograms and 6-minute walk tests over the next two years?
- 4.Is my current heart shape (right ventricular remodeling) improving as expected?
- 5.Do you recommend a specialized pulmonary rehabilitation program to help me regain my stamina?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (14)
- 1
A systematic review of the impact of pulmonary thromboendarterectomy on health-related quality of life.
Raguragavan A, Jayabalan D, Dhakal S, Saxena A
Pulmonary circulation 2024; (14(3)):e12407 doi:10.1002/pul2.12407.
PMID: 38962182 - 2
Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort.
Cannon JE, Su L, Kiely DG, et al.
Circulation 2016; (133(18)):1761-71 doi:10.1161/CIRCULATIONAHA.115.019470.
PMID: 27052413 - 3
Effects of postoperative rehabilitation on functional exercise capacity, dyspnea, and quality of life after pulmonary endarterectomy: a systematic review.
Polastri M
Journal of Yeungnam medical science 2025; (42()):32 doi:10.12701/jyms.2025.42.32.
PMID: 40205761 - 4
Right ventricular remodelling and long-term survival after pulmonary endarterectomy versus balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
Ravnestad H, Murbræch K, Gjønnæss E, et al.
Heart (British Cardiac Society) 2025; (111(3)):125-132 doi:10.1136/heartjnl-2024-324243.
PMID: 39467613 - 5
Residual Pulmonary Hypertension After Pulmonary Endarterectomy: The Fog Is Clearing.
Hoeper MM
Circulation 2016; (133(18)):1731-3 doi:10.1161/CIRCULATIONAHA.116.022595.
PMID: 27052412 - 6
The Surgical Management of Chronic Thromboembolic Pulmonary Hypertension.
McGann KC, Wang CC, Trahanas JM, et al.
Journal of clinical medicine 2025; (14(19)) doi:10.3390/jcm14196862.
PMID: 41095941 - 7
Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.
Kim NH, D'Armini AM, Grimminger F, et al.
Heart (British Cardiac Society) 2017; (103(8)):599-606 doi:10.1136/heartjnl-2016-309621.
PMID: 28011757 - 8
Prevention and treatment of the chronic thromboembolic pulmonary hypertension.
Pesavento R, Prandoni P
Thrombosis research 2018; (164()):150-156 doi:10.1016/j.thromres.2018.02.149.
PMID: 29526325 - 9
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Meta-analysis.
Kennedy MK, Kennedy SA, Tan KT, et al.
Cardiovascular and interventional radiology 2023; (46(1)):5-18 doi:10.1007/s00270-022-03323-8.
PMID: 36474104 - 10
Chronic Thromboembolic Pulmonary Hypertension: A Comprehensive Review and Multidisciplinary Approach to Surgical Treatment.
Al Abri Q, Lu AJ, Ramchandani MK
Methodist DeBakey cardiovascular journal 2021; (17(2)):e18-e28 doi:10.14797/IQTU6714.
PMID: 34377353 - 11
Anticoagulation in chronic thromboembolic pulmonary hypertension: an updated systematic review and meta-analysis.
Catalani F, Valeriani E, Ageno W, et al.
Internal and emergency medicine 2026; (21(3)):971-978 doi:10.1007/s11739-025-04257-y.
PMID: 41559250 - 12
Anxiety and Depression in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension after the Removal of COVID-19 Pandemic Restrictions.
Wieteska-Miłek M, Witowicz A, Szmit S, et al.
Journal of clinical medicine 2024; (13(12)) doi:10.3390/jcm13123532.
PMID: 38930062 - 13
Noninvasive follow-up strategy after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
Ruigrok D, Handoko ML, Meijboom LJ, et al.
ERJ open research 2022; (8(2)) doi:10.1183/23120541.00564-2021.
PMID: 35586450 - 14
Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension in Cape Town, South Africa.
Davies-van Es SA, Pennel TC, Brink J, et al.
African journal of thoracic and critical care medicine 2023; (29(3)) doi:10.7196/AJTCCM.2023.v29i3.294.
PMID: 37970576
This page provides general educational information about recovering from CTEPH treatments like PEA and BPA. Always consult your pulmonologist or cardiologist for personalized medical advice regarding your specific recovery plan and medications.
Get notified when new evidence is published on Chronic thromboembolic pulmonary hypertension.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.